You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開立醫療(300633.SZ):4K軟鏡已進入公司研發管線中 但尚未有明確時間表
格隆匯 02-10 15:22

格隆匯2月10日丨開立醫療(300633.SZ)於2023年2月7-10日在接受機構現場參觀時表示,根據公司與研發人員、臨牀醫生訪談了解,軟鏡屬於腔內成像,2K已滿足一般需求,相比硬鏡,軟鏡對圖像的分辨率要求沒那麼高,或者從醫生角度看臨牀對4K的需求沒有那麼迫切,醫生更看重在手術過程中軟鏡的穩定性、可操控性、可插入性、靈活度、軟硬度等臨牀體驗,因此目前市場上軟鏡極少有4K,硬鏡卻已大規模普及4K了,境外軟鏡廠家也是在最近一兩年才開始4K軟鏡的研發和推廣。

基於上述背景,對於軟鏡研發,公司目前重點工作是橫向擴充鏡體(如支氣管鏡、細鏡、十二指腸鏡、超聲內鏡等)、縱向豐富內鏡的高端功能(如光學放大內鏡、可變硬度鏡體等),在獲證後儘快實現批量交付;4K軟鏡已進入公司研發管線中,但尚未有明確時間表。另,軟鏡產品作為一種更看重穩定性的產品,本身更新迭代較慢,公司現階段仍在不斷打磨和豐富現有的550系列軟鏡產品,以期更好的滿足臨牀需求,暫未計劃推出下一代軟鏡。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account